| Daily Price Action: |
| Date |
Open |
High |
Low |
Close |
Volume |
| 2010-03-29 | 6.22 | 6.29 | 6.07 | 6.10 | 420000 |
| 2010-03-26 | 6.34 | 6.45 | 6.04 | 6.10 | 435700 |
| 2010-03-25 | 6.34 | 6.45 | 6.24 | 6.30 | 336500 |
| 2010-03-24 | 6.29 | 6.38 | 6.17 | 6.30 | 301300 |
| 2010-03-23 | 6.07 | 6.35 | 6.06 | 6.34 | 395600 |
| 2010-03-22 | 6.00 | 6.13 | 5.90 | 6.09 | 387300 |
| 2010-03-19 | 6.12 | 6.24 | 5.89 | 6.07 | 928100 |
| 2010-03-18 | 6.25 | 6.31 | 6.03 | 6.06 | 856100 |
| 2010-03-17 | 6.57 | 6.65 | 6.20 | 6.24 | 938300 |
| 2010-03-16 | 6.61 | 6.61 | 6.45 | 6.53 | 333900 |
| 2010-03-15 | 6.92 | 6.92 | 6.55 | 6.58 | 338700 |
| 2010-03-12 | 6.69 | 6.73 | 6.51 | 6.55 | 211200 |
| 2010-03-11 | 6.49 | 6.61 | 6.45 | 6.61 | 460300 |
| 2010-03-10 | 6.52 | 6.81 | 6.46 | 6.50 | 393600 |
| 2010-03-09 | 6.65 | 6.74 | 6.46 | 6.51 | 324400 |
| 2010-03-08 | 6.78 | 6.83 | 6.62 | 6.71 | 202300 |
| 2010-03-05 | 6.78 | 6.81 | 6.65 | 6.76 | 411700 |
| 2010-03-04 | 6.97 | 6.99 | 6.60 | 6.69 | 292500 |
| 2010-03-03 | 6.85 | 7.04 | 6.77 | 6.89 | 356600 |
| 2010-03-02 | 6.60 | 6.79 | 6.52 | 6.75 | 319100 |
| 2010-03-01 | 6.32 | 6.62 | 6.32 | 6.60 | 457800 |
| 2010-02-26 | 6.28 | 6.34 | 6.17 | 6.28 | 278100 |
| 2010-02-25 | 6.19 | 6.31 | 6.18 | 6.25 | 164700 |
| 2010-02-24 | 6.30 | 6.38 | 6.21 | 6.35 | 196400 |
| 2010-02-23 | 6.24 | 6.33 | 6.20 | 6.29 | 405300 |
| 2010-02-22 | 6.35 | 6.35 | 6.21 | 6.28 | 198600 |
| 2010-02-19 | 6.27 | 6.35 | 6.11 | 6.33 | 219600 |
| 2010-02-18 | 6.42 | 6.42 | 6.21 | 6.31 | 400300 |
| 2010-02-17 | 6.46 | 6.50 | 6.28 | 6.46 | 209000 |
| 2010-02-16 | 6.46 | 6.46 | 6.30 | 6.46 | 164400 |
| 2010-02-12 | 6.33 | 6.37 | 6.23 | 6.37 | 382100 |
| 2010-02-11 | 6.21 | 6.43 | 6.10 | 6.42 | 299400 |
|
| Recent Company Events: |
| 11-Jan-10 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits | | 18-Dec-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement | | 24-Nov-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 5-Nov-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report | | 4-Nov-09 | Orexigen Therapeutics, Inc. Earnings Call scheduled for 5:00 pm ET today | | 4-Nov-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or | | 1-Oct-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits | | 30-Sep-09 | Orexigen Therapeutics Empatic Phase 2B Results Call scheduled for 8:30 am ET today | | 30-Sep-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi | | 21-Sep-09 | Price hit new 52-week high ($10.83) | | 10-Sep-09 | Price hit new 52-week high ($9.67) | | 7-Aug-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report | | 6-Aug-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a | | 27-Jul-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits | | 22-Jul-09 | Price hit new 52-week high ($9.47) | | 20-Jul-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi | | 11-Jun-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement | | 2-Jun-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits | | 8-May-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report | | 7-May-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a | | 29-Apr-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers | | 1-Apr-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 13-Mar-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-K, Annual Report | | 12-Mar-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a | | 2-Mar-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 4-Feb-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement | | 29-Jan-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers | | 9-Jan-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu |
|